Effective patent life of drugs in Sweden—a comparison with international studies-Reference-Cited by-同舟云学术

Effective patent life of drugs in Sweden—a comparison with international studies

Published:1993-01 Issue:1 Volume:14 Page:53-63
ISSN:0143-6570
Container-title:Managerial and Decision Economics
language:en
Short-container-title:Manage. Decis. Econ.

Author:

Andersson F.,Hertzmant P.

Publisher

Wiley

Subject

Management of Technology and Innovation,Management Science and Operations Research,Strategy and Management,Business and International Management

Reference22 articles.

1. (1989). Effektiv patenttid for nya ladkemedels-substanser registrerade i Sverige 1965-1987 (Effective patent life of new chemical entities approved in Sweden between 1965 and 1987). Center for Medical Technology Assessment, CMT Rapport 1989:3, Linkoping: University of Linkoping.

2. (1987). Letter to the authors. April 1987.

3. Market life, age structure and renewal—an analysis of pharmaceutical specialities and substances in Sweden 1960–82

4. Commission of the European Communities (1989) Pharmaceuticals, Brussels: Panorama of EEC Industry.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical Detailing Elasticities: A Meta-Analysis;International Series in Quantitative Marketing;2013-10-26

2. Uncertainty in the generic versus brand name prescription decision;Empirical Economics;2009-03-06

3. Approval times and the safety of new pharmaceuticals;The European Journal of Health Economics;2004-11

4. Side effects of generic competition?;The European Journal of Health Economics, formerly: HEPAC;2004-09

5. The Market for Pharmaceuticals;Developments in Health Economics and Public Policy;1998